Latest Insider Transactions at Hims & Hers Health, Inc. (HIMS)
This section provides a real-time view of insider transactions for Hims & Hers Health, Inc. (HIMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hims & Hers Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hims & Hers Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,107
-26.77%
|
$1,086,029
$47.25 P/Share
|
|
Jun 17
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
8,485
-92.26%
|
$500,615
$59.75 P/Share
|
|
Jun 17
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.55%
|
$151,748
$59.75 P/Share
|
|
Jun 17
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
65,110
-22.02%
|
$3,776,380
$58.98 P/Share
|
|
Jun 17
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,102
-5.78%
|
$1,009,018
$59.75 P/Share
|
|
Jun 16
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,451
-3.18%
|
$305,256
$56.8 P/Share
|
|
Jun 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
128,127
-12.84%
|
$7,303,239
$57.07 P/Share
|
|
Jun 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+17.18%
|
$250,670
$2.43 P/Share
|
|
Jun 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-8.55%
|
$2,661,904
$56.67 P/Share
|
|
Jun 13
2025
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,787
-48.86%
|
$483,285
$55.48 P/Share
|
|
Jun 13
2025
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,984
+50.0%
|
-
|
|
Jun 13
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,282
-11.96%
|
$1,280,510
$55.48 P/Share
|
|
Jun 13
2025
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,420
+17.55%
|
-
|
|
Jun 13
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
58,023
-40.2%
|
$3,191,265
$55.48 P/Share
|
|
Jun 13
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105,199
+42.16%
|
-
|
|
Jun 13
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
90,672
-35.74%
|
$4,986,960
$55.48 P/Share
|
|
Jun 13
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
164,368
+39.32%
|
-
|
|
Jun 13
2025
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,166
-14.0%
|
$2,649,130
$55.48 P/Share
|
|
Jun 13
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
87,106
+20.23%
|
-
|
|
Jun 13
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,177
-2.62%
|
$339,735
$55.48 P/Share
|
|
Jun 13
2025
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,521
+6.54%
|
-
|
|
Jun 13
2025
|
Anja Manuel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,040
+28.67%
|
-
|
|
Jun 13
2025
|
Christopher D Payne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,040
+33.45%
|
-
|
|
Jun 12
2025
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+5.34%
|
-
|
|
Jun 12
2025
|
Kare Schultz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,118
+50.0%
|
-
|
|
Jun 12
2025
|
Garcia Andrea G Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+10.73%
|
-
|
|
Jun 12
2025
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+4.33%
|
-
|
|
Jun 12
2025
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+13.38%
|
-
|
|
Jun 12
2025
|
Deborah M. Autor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,175
+50.0%
|
-
|
|
Jun 12
2025
|
Anja Manuel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+39.95%
|
-
|
|
Jun 12
2025
|
Christopher D Payne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+50.0%
|
-
|
|
Jun 12
2025
|
Christiane Pendarvis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+21.37%
|
-
|
|
Jun 10
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,600
-2.14%
|
$319,200
$57.0 P/Share
|
|
Jun 10
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,400
+2.02%
|
$32,400
$6.82 P/Share
|
|
Jun 06
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,100
-0.98%
|
$285,600
$56.0 P/Share
|
|
Jun 06
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,100
+0.97%
|
$61,200
$12.72 P/Share
|
|
Jun 05
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,776
+10.08%
|
$374,088
$13.9 P/Share
|
|
May 28
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-22.83%
|
$602,212
$52.98 P/Share
|
|
May 28
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+5.08%
|
$32,185
$5.01 P/Share
|
|
May 27
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,233
-2.07%
|
$177,815
$55.87 P/Share
|
|
May 22
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
5,071
-100.0%
|
$268,763
$53.51 P/Share
|
|
May 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
128,127
-17.23%
|
$7,431,366
$58.74 P/Share
|
|
May 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+24.6%
|
$250,670
$2.43 P/Share
|
|
May 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-7.42%
|
$2,756,972
$58.28 P/Share
|
|
May 15
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-9.24%
|
$694,860
$60.22 P/Share
|
|
May 15
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+2.47%
|
$51,496
$8.27 P/Share
|
|
May 12
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,235
-2.03%
|
$181,160
$56.0 P/Share
|
|
May 12
2025
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
33,333
-1.01%
|
$1,866,648
$56.38 P/Share
|
|
May 12
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+3.82%
|
$66,666
$2.43 P/Share
|
|
Apr 29
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-35.19%
|
$1,800,000
$36.39 P/Share
|